Zoetis Inc (ZTS)
151.99
-1.03
(-0.67%)
USD |
NYSE |
Apr 17, 16:00
151.99
0.00 (0.00%)
After-Hours: 20:00
Zoetis Cash from Financing (TTM): -3.109B for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.109B |
| September 30, 2023 | -1.932B |
| June 30, 2023 | -2.045B |
| March 31, 2023 | -2.161B |
| December 31, 2022 | -904.00M |
| September 30, 2022 | -1.998B |
| June 30, 2022 | -2.388B |
| March 31, 2022 | -2.068B |
| December 31, 2021 | -1.862B |
| September 30, 2021 | -2.145B |
| June 30, 2021 | -1.319B |
| March 31, 2021 | 112.00M |
| December 31, 2020 | 123.00M |
| September 30, 2020 | 470.00M |
| June 30, 2020 | 331.00M |
| March 31, 2020 | -1.036B |
| December 31, 2019 | -951.00M |
| September 30, 2019 | -898.00M |
| June 30, 2019 | 597.00M |
| March 31, 2019 | 552.00M |
| December 31, 2018 | 533.00M |
| September 30, 2018 | -237.00M |
| June 30, 2018 | -544.00M |
| March 31, 2018 | -337.00M |
| December 31, 2017 | -251.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 588.00M |
| June 30, 2017 | -492.00M |
| March 31, 2017 | -536.00M |
| December 31, 2016 | -903.00M |
| September 30, 2016 | 251.00M |
| June 30, 2016 | 289.00M |
| March 31, 2016 | 306.00M |
| December 31, 2015 | 755.00M |
| September 30, 2015 | -313.00M |
| June 30, 2015 | -265.00M |
| March 31, 2015 | -213.00M |
| December 31, 2014 | -154.00M |
| September 30, 2014 | -140.00M |
| June 30, 2014 | -134.00M |
| March 31, 2014 | -127.00M |
| December 31, 2013 | -200.00M |
| September 30, 2013 | -250.00M |
| June 30, 2013 | -236.00M |
| March 31, 2013 | -257.00M |
| December 31, 2012 | -78.00M |
| September 30, 2012 | -152.00M |
| June 30, 2012 | -262.00M |
| March 31, 2012 | -310.00M |
| December 31, 2011 | -30.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.109B
Minimum
Dec 2023
597.00M
Maximum
Jun 2019
-1.220B
Average
-1.319B
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
| Biogen Inc | 149.30M |
| Eli Lilly and Co | 3.496B |
| Pfizer Inc | 26.07B |
| Abbott Laboratories | -7.091B |
| Bristol-Myers Squibb Co | -9.416B |